BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Wu L, Zhang Y, Zhu Y, Cong Q, Xiang Y, Fu L. The effect of LOXL2 in hepatocellular carcinoma. Mol Med Rep 2016;14:1923-32. [PMID: 27430160 DOI: 10.3892/mmr.2016.5474] [Cited by in Crossref: 10] [Cited by in F6Publishing: 12] [Article Influence: 1.7] [Reference Citation Analysis]
Number Citing Articles
1 Zhang Y, Liu W, Xu J. Prognostic utility and clinical significance of lysyl oxidase‐like 2 protein expression in digestive system cancers. J Cell Physiol 2019;234:20713-20. [DOI: 10.1002/jcp.28677] [Cited by in Crossref: 5] [Cited by in F6Publishing: 4] [Article Influence: 1.7] [Reference Citation Analysis]
2 Li R, Wang Y, Zhang X, Feng M, Ma J, Li J, Yang X, Fang F, Xia Q, Zhang Z, Shang M, Jiang S. Exosome-mediated secretion of LOXL4 promotes hepatocellular carcinoma cell invasion and metastasis. Mol Cancer. 2019;18:18. [PMID: 30704479 DOI: 10.1186/s12943-019-0948-8] [Cited by in Crossref: 54] [Cited by in F6Publishing: 60] [Article Influence: 18.0] [Reference Citation Analysis]
3 Ye M, Song Y, Pan S, Chu M, Wang ZW, Zhu X. Evolving roles of lysyl oxidase family in tumorigenesis and cancer therapy. Pharmacol Ther 2020;215:107633. [PMID: 32693113 DOI: 10.1016/j.pharmthera.2020.107633] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 4.0] [Reference Citation Analysis]
4 Zhao W, Yang A, Chen W, Wang P, Liu T, Cong M, Xu A, Yan X, Jia J, You H. Inhibition of lysyl oxidase-like 1 (LOXL1) expression arrests liver fibrosis progression in cirrhosis by reducing elastin crosslinking. Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease 2018;1864:1129-37. [DOI: 10.1016/j.bbadis.2018.01.019] [Cited by in Crossref: 21] [Cited by in F6Publishing: 21] [Article Influence: 5.3] [Reference Citation Analysis]
5 Cai H, Xie X, Ji L, Ruan X, Zheng Z. Sphingosine kinase 1: A novel independent prognosis biomarker in hepatocellular carcinoma. Oncol Lett 2017;13:2316-22. [PMID: 28454397 DOI: 10.3892/ol.2017.5732] [Cited by in Crossref: 15] [Cited by in F6Publishing: 15] [Article Influence: 3.0] [Reference Citation Analysis]
6 Choi J, Chung T, Rhee H, Kim YJ, Jeon Y, Yoo JE, Noh S, Han DH, Park YN. Increased Expression of the Matrix-Modifying Enzyme Lysyl Oxidase-Like 2 in Aggressive Hepatocellular Carcinoma with Poor Prognosis. Gut Liver 2019;13:83-92. [PMID: 29938458 DOI: 10.5009/gnl17569] [Cited by in Crossref: 9] [Cited by in F6Publishing: 11] [Article Influence: 3.0] [Reference Citation Analysis]
7 Wen L, Hu J, Zhang J, Yang J. Phenylethanol glycosides from Herba Cistanche improve the hypoxic tumor microenvironment and enhance the effects of oxaliplatin via the HIF‑1α signaling pathway. Mol Med Rep 2021;24:517. [PMID: 34013363 DOI: 10.3892/mmr.2021.12156] [Reference Citation Analysis]
8 Ferreira S, Saraiva N, Rijo P, Fernandes AS. LOXL2 Inhibitors and Breast Cancer Progression. Antioxidants (Basel) 2021;10:312. [PMID: 33669630 DOI: 10.3390/antiox10020312] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
9 Zhang F, Xu C, Ning L, Hu F, Shan G, Chen H, Yang M, Chen W, Yu J, Xu G. Exploration of Serum Proteomic Profiling and Diagnostic Model That Differentiate Crohn's Disease and Intestinal Tuberculosis. PLoS One 2016;11:e0167109. [PMID: 27997555 DOI: 10.1371/journal.pone.0167109] [Cited by in Crossref: 11] [Cited by in F6Publishing: 10] [Article Influence: 1.8] [Reference Citation Analysis]
10 Craighead DH, Wang H, Santhanam L, Alexander LM. Acute lysyl oxidase inhibition alters microvascular function in normotensive but not hypertensive men and women. Am J Physiol Heart Circ Physiol 2018;314:H424-33. [PMID: 29167120 DOI: 10.1152/ajpheart.00521.2017] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 1.8] [Reference Citation Analysis]
11 Fan Z, Zheng W, Li H, Wu W, Liu X, Sun Z, Hu H, Du L, Jia Q, Liu Q. LOXL2 upregulates hypoxia‑inducible factor‑1α signaling through Snail‑FBP1 axis in hepatocellular carcinoma cells. Oncol Rep 2020;43:1641-9. [PMID: 32323822 DOI: 10.3892/or.2020.7541] [Cited by in Crossref: 2] [Cited by in F6Publishing: 4] [Article Influence: 1.0] [Reference Citation Analysis]
12 Lin HY, Li CJ, Yang YL, Huang YH, Hsiau YT, Chu PY. Roles of Lysyl Oxidase Family Members in the Tumor Microenvironment and Progression of Liver Cancer. Int J Mol Sci 2020;21:E9751. [PMID: 33371259 DOI: 10.3390/ijms21249751] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]